{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:50:43Z","timestamp":1790142643984,"version":"4.0.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA230201"],"award-info":[{"award-number":["R00CA230201"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tumor-infiltrating lymphocyte (TIL) adoptive cell therapy is effective in treating malignant melanoma, but its success relies on the adequate ex vivo expansion of TIL. To assess correlates of TIL expansion, CD4+ and CD8+ TIL were analyzed by RNA sequencing (RNA-seq) and chromatin immunoprecipitation sequencing of acetylated histone 3. Patients were grouped into \u201cTIL high\u201d and \u201cTIL low\u201d based on division at the median number of TIL infused. Greater numbers of TIL infused correlated with longer overall survival, and increased frequencies of CD4+ cells infused were negatively correlated with the number of TIL infused. RNA-seq analysis of CD4+ TIL showed increases in Th2\/Th17\/regulatory T cell\u2013related transcripts and pathways in the TIL-low group. Analysis of a public single-cell RNA-seq dataset validated findings that increased frequencies of CD4+ cells were negatively correlated with the number of TIL infused. TIL-low patients had significantly increased frequencies of CD4+ cells expressing ETS2 and OSM and trended toward increased expression of TNFRSF18.<\/jats:p>","DOI":"10.4049\/jimmunol.2300250","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T13:34:04Z","timestamp":1689773644000},"page":"735-742","source":"Crossref","is-referenced-by-count":6,"title":["CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy"],"prefix":"10.1093","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0983-2762","authenticated-orcid":false,"given":"Brian","family":"Thompson","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, University of Colorado , Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6655-0959","authenticated-orcid":false,"given":"Ann","family":"Strange","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, University of Colorado , Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4945-8819","authenticated-orcid":false,"given":"Carol M","family":"Amato","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, University of Colorado , Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0667-0307","authenticated-orcid":false,"given":"Jonathan","family":"Hester-McCullough","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, University of Colorado , Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-5898","authenticated-orcid":false,"given":"Amod A","family":"Sarnaik","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center , Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Weber","sequence":"additional","affiliation":[{"name":"Laura and Isaac Perlmutter Cancer Center, NYU Langone Health , New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6328-8107","authenticated-orcid":false,"given":"David M","family":"Woods","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Medicine, University of Colorado , Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"2025020406085014200_r1","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/annonc\/mdz398","article-title":"Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis","volume":"30","author":"Dafni","year":"2019","journal-title":"Ann. Oncol."},{"key":"2025020406085014200_r2","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1200\/JCO.21.00612","article-title":"Lifileucel, a tumor-infiltrating lymphocyte therapy, in metastatic melanoma. [Published erratum appears in 2021 J. Clin. Oncol. 39: 2972.]","volume":"39","author":"Sarnaik","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"2025020406085014200_r3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40425-018-0391-1","article-title":"Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option","volume":"6","author":"Rohaan","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"2025020406085014200_r4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/CJI.0b013e31826e8f5f","article-title":"Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma","volume":"35","author":"Pilon-Thomas","year":"2012","journal-title":"J. Immunother."},{"key":"2025020406085014200_r5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fonc.2018.00044","article-title":"Combination of ipilimumab and adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic melanoma","volume":"8","author":"Mullinax","year":"2018","journal-title":"Front. Oncol."},{"key":"2025020406085014200_r6","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1158\/1078-0432.CCR-18-2725","article-title":"BRAF targeting sensitizes resistant melanoma to cytotoxic T cells","volume":"25","author":"Atay","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"2025020406085014200_r7","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"2025020406085014200_r8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"2025020406085014200_r9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"2025020406085014200_r10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"2025020406085014200_r11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2025020406085014200_r12","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"2025020406085014200_r13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature10730","article-title":"Differential oestrogen receptor binding is associated with clinical outcome in breast cancer","volume":"481","author":"Ross-Innes","year":"2012","journal-title":"Nature"},{"key":"2025020406085014200_r14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. B"},{"key":"2025020406085014200_r15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"2025020406085014200_r16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.abb9847","article-title":"Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer","volume":"370","author":"Krishna","year":"2020","journal-title":"Science"},{"key":"2025020406085014200_r17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/gene.2011.9","article-title":"LIF in the regulation of T-cell fate and as a potential therapeutic","volume":"12","author":"Metcalfe","year":"2011","journal-title":"Genes Immun."},{"key":"2025020406085014200_r18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0960-9822(98)70134-4","article-title":"A distinct role for interleukin-13 in Th2-cell-mediated immune responses","volume":"8","author":"McKenzie","year":"1998","journal-title":"Curr. Biol."},{"key":"2025020406085014200_r19","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat. Immunol."},{"key":"2025020406085014200_r20","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2011-12-396101","article-title":"IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity","volume":"119","author":"Tran","year":"2012","journal-title":"Blood"},{"key":"2025020406085014200_r21","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4049\/jimmunol.1502314","article-title":"Oncostatin M suppresses activation of IL-17\/Th17 via SOCS3 regulation in CD4+ T cells","volume":"198","author":"Son","year":"2017","journal-title":"J. Immunol."},{"key":"2025020406085014200_r22","doi-asserted-by":"crossref","first-page":"e0199156","DOI":"10.1371\/journal.pone.0199156","article-title":"Activation of Th2 cells downregulates CRTh2 through an NFAT1 mediated mechanism","volume":"13","author":"MacLean Scott","year":"2018","journal-title":"PLoS One"},{"key":"2025020406085014200_r23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation","volume":"50","author":"Miragaia","year":"2019","journal-title":"Immunity"},{"key":"2025020406085014200_r24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1177\/0022034518759302","article-title":"RANKL triggers Treg-mediated immunoregulation in inflammatory osteolysis","volume":"97","author":"Francisconi","year":"2018","journal-title":"J. Dent. Res."},{"key":"2025020406085014200_r25","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1038\/s41467-020-20138-8","article-title":"Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells","volume":"11","author":"G\u00f3mez-Aleza","year":"2020","journal-title":"Nat. Commun."},{"key":"2025020406085014200_r26","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3389\/fimmu.2019.01447","article-title":"Regulation of CD4+ T cell signaling and immunological synapse by protein tyrosine phosphatases: molecular mechanisms in autoimmunity","volume":"10","author":"Castro-S\u00e1nchez","year":"2019","journal-title":"Front. Immunol."},{"key":"2025020406085014200_r27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbrc.2009.09.117","article-title":"Protein-tyrosine phosphatase-kappa regulates CD4+ T cell development through ERK1\/2-mediated signaling","volume":"390","author":"Erdenebayar","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2025020406085014200_r28","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1084\/jem.20150186","article-title":"The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection","volume":"212","author":"Dominguez","year":"2015","journal-title":"J. Exp. Med."},{"key":"2025020406085014200_r29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.molimm.2007.07.013","article-title":"The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes","volume":"45","author":"Rijkers","year":"2008","journal-title":"Mol. Immunol."},{"key":"2025020406085014200_r30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcmd.2016.04.013","article-title":"APOBEC3G has the ability to programme T cell plasticity","volume":"59","author":"Garg","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"key":"2025020406085014200_r31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/CJI.0b013e3181d367bd","article-title":"Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy","volume":"33","author":"Prieto","year":"2010","journal-title":"J. Immunother."},{"key":"2025020406085014200_r32","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1158\/1078-0432.CCR-13-0380","article-title":"Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies","volume":"19","author":"Besser","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"2025020406085014200_r33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/CJI.0b013e31825898c5","article-title":"Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes","volume":"35","author":"Friedman","year":"2012","journal-title":"J. Immunother."},{"key":"2025020406085014200_r34","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1056\/NEJMoa0800251","article-title":"Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1","volume":"358","author":"Hunder","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2025020406085014200_r35","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1038\/cti.2017.37","article-title":"Adoptive cell therapy with CD4+ T helper 1 cells and CD8+ cytotoxic T cells enhances complete rejection of an established tumour, leading to generation of endogenous memory responses to non-targeted tumour epitopes","volume":"6","author":"Li","year":"2017","journal-title":"Clin. Transl. Immunology"},{"key":"2025020406085014200_r36","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/PPO.0b013e31824d4465","article-title":"Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook","volume":"18","author":"Wu","year":"2012","journal-title":"Cancer J."},{"key":"2025020406085014200_r37","doi-asserted-by":"crossref","first-page":"750542","DOI":"10.3389\/fimmu.2021.750542","article-title":"Regulatory T cells: regulation of identity and function","volume":"12","author":"Grover","year":"2021","journal-title":"Front. Immunol."},{"key":"2025020406085014200_r38","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.4049\/jimmunol.169.9.4873","article-title":"The role of the Ets2 transcription factor in the proliferation, maturation, and survival of mouse thymocytes","volume":"169","author":"Zaldumbide","year":"2002","journal-title":"J. Immunol."},{"key":"2025020406085014200_r39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1074-7613(02)00280-7","article-title":"CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor","volume":"16","author":"McHugh","year":"2002","journal-title":"Immunity"},{"key":"2025020406085014200_r40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mad.2009.11.003","article-title":"Maintenance of na\u00efve CD8 T cells in nonagenarians by leptin, IGFBP3 and T3","volume":"131","author":"Chen","year":"2010","journal-title":"Mech. Ageing Dev."},{"key":"2025020406085014200_r41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"key":"2025020406085014200_r42","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1158\/1078-0432.CCR-15-1879","article-title":"Long-lasting complete responses in patients with metastatic melanoma after adoptive cell therapy with tumor-infiltrating lymphocytes and an attenuated IL2 regimen","volume":"22","author":"Andersen","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"2025020406085014200_r43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1479-5876-10-169","article-title":"Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients","volume":"10","author":"Ellebaek","year":"2012","journal-title":"J. Transl. Med."},{"key":"2025020406085014200_r44","doi-asserted-by":"crossref","first-page":"705422","DOI":"10.3389\/fimmu.2021.705422","article-title":"Rapid identification of the tumor-specific reactive TIL repertoire via combined detection of CD137, TNF, and IFN\u03b3, following recognition of autologous tumor-antigens","volume":"12","author":"Draghi","year":"2021","journal-title":"Front. Immunol."},{"key":"2025020406085014200_r45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"2025020406085014200_r46","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.4049\/jimmunol.174.5.2591","article-title":"CD8+ T cell immunity against a tumor\/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells","volume":"174","author":"Antony","year":"2005","journal-title":"J. Immunol."},{"key":"2025020406085014200_r47","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.4049\/jimmunol.176.12.7726","article-title":"Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy","volume":"176","author":"Huang","year":"2006","journal-title":"J. Immunol."},{"key":"2025020406085014200_r48","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"2025020406085014200_r49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40425-019-0517-0","article-title":"HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics","volume":"7","author":"Laino","year":"2019","journal-title":"J. Immunother. Cancer"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/211\/5\/735\/61472884\/ji2300250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/211\/5\/735\/61472884\/ji2300250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T06:09:10Z","timestamp":1738649350000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/211\/5\/735\/7927352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.2300250","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,7,19]]}}}